financetom
Business
financetom
/
Business
/
BMO Comments on The Canadian Dollar Early Wednesday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO Comments on The Canadian Dollar Early Wednesday
Nov 27, 2024 4:56 AM

07:44 AM EST, 11/27/2024 (MT Newswires) -- The US dollar is weaker (BBDXY -0.3%) early Wednesday with the Canadian dollar (CAD or loonie) essentially flat, said Bank of Montreal (BMO).

There is no Canadian macroeconomic data due out on Wednesday, stated the bank.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Prologis raises full-year forecast, cites stabilizing demand
Prologis raises full-year forecast, cites stabilizing demand
Oct 17, 2024
Oct 16 (Reuters) - Real estate investment trust (REIT) Prologis ( PLD ) raised the lower end of its full-year forecast for adjusted core funds from operations on Wednesday due to strong long-term demand drivers, sending its shares up 1.5% in premarket. The warehouse-focused REIT said the decline in business activity, which began after a downturn in freight demand post...
Sector Update: Consumer Stocks Edge Higher Premarket Wednesday
Sector Update: Consumer Stocks Edge Higher Premarket Wednesday
Oct 17, 2024
09:13 AM EDT, 10/16/2024 (MT Newswires) -- Consumer stocks were edging higher premarket Wednesday as the Consumer Staples Select Sector SPDR Fund ( XLP ) was slightly advancing and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) was up 0.1% recently. Container Store Group ( TCS ) shares advanced by over 37% after the company said it signed...
Novavax's COVID-19-Influenza Vaccine Trial Put on Clinical Hold, Shares Fall
Novavax's COVID-19-Influenza Vaccine Trial Put on Clinical Hold, Shares Fall
Oct 17, 2024
09:18 AM EDT, 10/16/2024 (MT Newswires) -- Novavax ( NVAX ) said Wednesday that the US Food and Drug Administration has placed a clinical hold on its investigational new drug application for its COVID-19-influenza combination and standalone influenza vaccine candidates. The company said the clinical hold is due to a report of a serious adverse event involving motor neuropathy in...
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
Oct 17, 2024
Novavax Inc. ( NVAX ) stock is trading lower on Wednesday. The FDA has placed a clinical hold on Novavax’s Investigational New Drug (IND) application for its COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates. The clinical hold is due to a spontaneous report of a serious adverse event (SAE) of motor neuropathy in a single CIC Phase 2 trial participant outside...
Copyright 2023-2026 - www.financetom.com All Rights Reserved